View Author
marmoset b cells antibody monkey model anti-bly effect anti-april group jagessar rhmog spleen treatment disease anti-cd 20 mab calhv laman jd 20+ bauer j depletion study marmoset eae model blood control cd 20 laman sclerosis animal subset immunol cd 20+ cells level brain demyelination calhv 3 proliferation mog 34−56 anti-cd pathway blcmog experiment t cells lymphoid organs anti-april mab calhv 3 dna analysis bauer blezer encephalomyeliti peptide april immunization blezer e 2012 b eae model b cell depletion il -17a survival cytokine netherland myelin activation research culture development panel γ- herpesvirus matter epitope 34−56 heijmans n cd 20+cd score primate transcript infection 20+cd recipient myelin oligodendrocyte glycoprotein sibling
2 Most Recent Publications
|
The Different Clinical Effects of Anti-BLyS, Anti-APRIL and Anti-CD20 Antibodies Point at a Critical Pathogenic Role of γ-Herpesvirus Infected B Cells in the Marmoset EAE Model
(Article)
Jagessar, S.A. Fagrouch, Z. Heijmans, N. Bauer, J. Laman, J.D. Oh, L. Migone, T.S. Verschoor, E.J. Hart, B. 't |
2013-03-19
|
|
Antibodies Against Human BLyS and APRIL Attenuate EAE Development in Marmoset Monkeys
(Article)
Jagessar, S.A. Heijmans, N. Bauer, J. Blezer, E. Laman, J.D. Migone, T.S. Devalaraja, M.N. Hart, B. 't |
2012-07-02
|
